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Ethnopharmacological relevance: Seventeen plants used in Vietnamese traditional medicine for the
treatment of inﬂammatory disorders were screened for NF-κB inhibitory activity. Oroxylum indicum,
which exhibited activity, was investigated in detail.
Materials and methods: Forty plant extracts from 17 species were prepared by maceration using
dichloromethane and methanol and were tested (10 mg/mL) to evaluate their ability to inhibit NF-κB
activation using TNF-α-stimulated HEK-293 cells stably transfected with a NF-κB-driven luciferase
reporter. The active extract of Oroxylum indicum was subsequently fractionated by different chromato-
graphic techniques. After isolation, all single compounds were identiﬁed by spectroscopic methods and
assessed for NF-κB inhibitory effects.
Results: The dichloromethane extracts obtained from Chromolaena odorata leaves and the stem bark of
Oroxylum indicum showed distinct inhibitory effects on NF-κB activation at a concentration of 10 mg/mL.
The active extract of Oroxylum indicum was subjected to further phytochemical studies resulting in
identiﬁcation of four ﬂavonoid aglyca and six ﬂavonoid glycosides. Pharmacological evaluation of the
obtained compounds identiﬁed oroxylin A as the most active substance (IC50¼3.9 mM, 95% CI: 3.5–
4.4 mM), while chrysin and hispidulin showed lower activity with IC50¼7.2 mM (95% CI: 6.0–8.8 mM) and
9.0 mM (95% CI: 7.9–10.2 mM), respectively. Interestingly, in this study the activity of baicalein
(IC50¼28.1 mM, 95% CI: 24.6–32.0 mM) was weak. The isolated glycosides showed no inhibitory activity
when tested at a concentration of 30 mM. Quantiﬁcation of the four active ﬂavonoids in extracts and plant
materials suggested that oroxylin A contributes to the NF-κB inhibitory activity of the stem barks of
Oroxylum indicum to a greater extent than baicalein which was thought to be responsible for the anti-
inﬂammatory activity of this plant.
Conclusions: The screening presented in this study identiﬁed the dichloromethane extracts of Chromo-
laena odorata and Oroxylum indicum as promising sources for NF-κB inhibitors. Hispidulin, baicalein,
chrysin and oroxylin A, isolated from Oroxylum indicum, were identiﬁed as inhibitors of NF- κB activation.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Inﬂammation is a response of organisms to the presence of pat-
hogens and chemical or mechanical injury. Although it is a defense
mechanism, the complex events and mediators in the uncon-
trolled inﬂammation reaction can induce or sustain a pathologic
process involved in different diseases e.g. arthritis, atherosclerosis,
allergy, the metabolic syndrome, sepsis and auto-immune diseases
as well as cancer (Libby et al., 2002; Allavena et al., 2008). Initi-
ation and promotion of inﬂammatory processes require synthesis
of effector proteins such as cell adhesion molecules (VCAM-1,
ICAM-1), inducible enzymes (COX-2 and iNOS), chemokines (MCP-
1, MIP-1α), cytokines and growth factors (tumor necrosis factor
alpha (TNF-α), interleukins) (Sacca et al., 1997; Eppihimer, 1998).
Thus, one strategy to block inﬂammation is to inhibit inﬂamma-
tory mediators on the transcriptional level. Among the involved
transcription factors, nuclear factor kappa B (NF-κB) plays a pro-
minent role. Therefore, the NF-κB signaling pathway represents an
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established target for anti-inﬂammatory drug discovery (Sun and
Andersson, 2002; Gupta et al., 2010). Besides synthetic com-
pounds, several natural products have been identiﬁed to inhibit
NF-κB (Bremner and Heinrich, 2002, 2005; Calixto et al., 2003;
Gupta et al., 2010; Baumgartner et al., 2011).
In Vietnam, traditional medicine has a long established history
and plays an important role in the health care system. Vietnam's
territory with an area of more than 3,30,000 square kilometers has
a number of key ecosystems including a variety of marine and
coastal habitats, wetland, and two important river deltas and is
known as a hot spot of biodiversity covering more than 12,000
plant species (Nguyen et al., 2007). Many of these plants have been
used to treat diseases and traditional knowledge is still preserved.
In 2009, Nguyen and You screened 87 plants used in Vietnamese
traditional medicine for inhibitory activity on NF-κB activation and
identiﬁed seven methanolic extracts as potential inhibitors of this
pathway. In a continuing effort to rationalize and assess the
activity of medicinal plants in Vietnam for inﬂammatory diseases,
we conducted a screening of 17 plants which are listed in the
textbook “Medicinal plants and animals in Vietnam (National
Institute of Medicinal Materials, 2004)”. Two of the plant extracts
showed promising inhibitory activity on NF-κB activation: the
dichloromethane extracts of Oroxylum indicum and Chromolaena
odorata. In 2010, Siriwatanametanon et al. found that the ethyl
acetate extract of Oroxylum indicum possesses NF-κB inhibitory
activity; however, identiﬁcation of the responsible compound
(s) was not described.
2. Materials and methods
2.1. Plant material
The plant material used in this study was collected from different
locations in the south of Vietnam between March and September
2010. The collected species were identiﬁed and authenticated by
taxonomists from the Department of Pharmacognosy, Faculty of
Pharmacy, University of Medicine and Pharmacy of HoChiMinh city.
Voucher specimens of plants are deposited in the herbarium of the
Pharmacognosy Department at University of Medicine and Pharmacy
of HoChiMinh city (Table 1). Additional samples of the stem bark of
Oroxylum indicum were collected in CuChi (sample Oro-1), in the
botanical garden of Faculty of Pharmacy (HoChiMinh city; sample
Oro-2), while sample Oro-3 and Oro-4 were collected in BinhPhuoc.
All plant samples were air-dried and ﬁnally ground to a ﬁne powder
before further processing.
2.2. Extraction
2.2.1. Preparation of extracts for screening
Finely ground plant material (5 g) was extracted with 50 mL
dichloromethane by sonication for 10 min at room temperature.
The plant material was recovered by ﬁltration and the process was
repeated three times with fresh solvent. The obtained solutions
were combined and evaporated to dryness using a rotavapor to
give dichloromethane extracts. The residual plant material was air-
dried and subsequently extracted with methanol using the same
procedure as described above to yield the corresponding methanol
extracts. All dried extracts were dissolved in dimethyl sulfoxide
(DMSO) prior to bioactivity evaluation.
2.2.2. Extraction of the stem bark of Oroxylum indicum for
quantiﬁcation purposes
Dried stem barks of Oroxylum indicum were cut into pieces and
ground to a ﬁne powder. The plant material (0.5 g) was extracted
ﬁve times with 40 mL of methanol by sonication (15 min each, at
ambient temperature) and then centrifuged at 3300 rpm for 7 min.
Extracts were combined, evaporated under reduced pressure and
subsequently re-dissolved in methanol, quantitatively transferred
to a volumetric ﬂask and adjusted to the ﬁnal volume (10 mL) with
methanol. Prior to injection, all solutions were ﬁltered through
cotton wool. Each sample solution was assayed in triplicate.
2.3. NF-κB activity and cell viability
HEK293/NF-κB-luc cells (Panomics, RC0014), a HEK293 cell line
stably transfected with NF-κB luciferase reporter, were used to
determine NF-κB activity and cell viability as previously described
(Vogl et al., 2013). Brieﬂy, cells were maintained at 37 1C and 5% CO2
atmosphere in Dulbecco's modiﬁed Eagle's medium (DMEM; Lonza,
Basel, Switzerland) with 100 U/mL benzylpenicillin 100 μg/mL strep-
tomycin, 2 mM glutamine, and 10% fetal bovine serum (FBS). Before
seeding in 96-well plates, cells were stained for 1 h in serum-free
medium supplemented with 2 μM Cell Tracker Green CMFDA (Invitro-
gen), a ﬂuorescent probe that is retained inside living cells and thus
can be used to monitor cell membrane integrity and cell viability
(Markasz et al., 2007; Stern et al., 2008; Johnson-Lyles et al., 2010;
Vogl et al., 2013). Cells were then plated in 96-well plates
(4104 cells/well) in phenol red-free and FBS-free DMEM overnight.
The following morning, cells were pretreated with the investigated
samples, positive control (parthenolide, 10 or 5 mM; IC50 value: 1.5 mM,
95% CI 1.3–1.8 mM) or solvent vehicle (0.1% DMSO in culture medium)
for 30min and stimulated with 2 ng/mL TNF-α for 4 h. Afterwards, the
cells were lysed with a luciferase lysis buffer (Promega; E1531) and the
luminescence of the ﬁreﬂy luciferase and the ﬂuorescence of the Cell
Tracker Green CMFDA were measured with a Genios Pro plate reader
(Tecan, Grödig, Austria). For quantiﬁcation of NF-κB activity, the
luciferase-derived signal from the NF-κB reporter was normalized by
the ﬂuorescence signal derived from Cell Tracker Green CMFDA to
account for differences in the cell number. Potential differences in
viable cell numbers were detected by comparison of the Cell Tracker
Green CMFDA ﬂuorescence of the solvent vehicle treated cells and
cells treated with the investigated samples.
2.4. Statistical analyses
Nonlinear regression (with sigmoidal dose response) was used
to calculate the IC50 values using GraphPad Prisms 4.03 (GraphPad
Software, Inc.). Statistical differences were compared with ANOVA
with Tukey's post-hoc test. P valueso0.05 were considered to be
signiﬁcant.
2.5. Chromatography and NMR analysis
Fast Centrifugal Partition Chromatography (FCPC) (Kromaton,
France) was equipped with Gilson 302/803 C pump system model
302 (Villiers-la-Bel, France).
LC for quantiﬁcation—LC-parameter: HP 1090 system (Agilent,
Waldbronn, Germany) equipped with autosampler, DAD and column
thermostat; stationary phase: Zorbax SB-C18 column (1504.6 mm,
3.5 mm particle size); mobile phase: solvent A: H2O with 0.5% formic
acid (v/v); solvent B: methanol; DAD: 275 nm, temp.: 40.0 1C;
injection volume: 5 μL; ﬂow: 0.3 mL/min; composition during run:
start: 40% B; 37 min: 70% B; 50 min: 75% B; 51 min: 98% B; 60 min:
stop; post-time: 10 min.
LC–MS—LC-parameter: HP 1100 system (Agilent, Waldbronn,
Germany) was equipped with auto-sampler, DAD and column
thermostat. MS-parameters: Esquire 3000plus (Bruker Daltonics, Bre-
men, Germany); ESI, temperature: 350 1C; dry gas: 10.00 L/min;
nebulizer 40 psi; full scan mode: m/z 100–1500.
NMR: 1D- and 2D-experiments were measured on a Bruker
DRX 300 (Bruker Biospin Rheinstetten, Germany) operating at
T.V.A. Tran et al. / Journal of Ethnopharmacology 159 (2015) 36–42 37
300.13 MHz (1H) and 75.47 MHz (13C) at 300 K (chemical shifts δ in
ppm, coupling constants J in Hz); NMR solvent: MeOH-d4 or
DMSO-d6 with 0.03% TMS (Eurisotop Gif-Sur-Yvette, France),
which was used as an internal standard.
2.6. Extraction, puriﬁcation and identiﬁcation of pure compounds
from Oroxylum indicum
Dried stem barks of Oroxylum indicum (Oro-1) (100 g) were
ground to a ﬁne powder and extracted with 500 mL methanol at
room temperature (10 times). After removal of the solvent under
reduced pressure, the resulting crude extract (16.10 g) was sus-
pended in 300 mL of H2O and successively extracted with petro-
leum ether (300 mL4), ethyl acetate (300 mL4) and water
saturated n-BuOH (300 mL4). The resulting extracts were con-
centrated under reduced pressure, to give petroleum ether
(0.72 g), ethyl acetate (0.85 g), n-butanol (2.74 g) and water
(11.24 g) extracts. The ethyl acetate extract (0.85 g) was subjected
to silica gel (40–63 μm, Merck, Darmstadt, Germany; 100 g)
column chromatography, using a CH2Cl2/MeOH gradient with
increasing amounts of MeOH as mobile phase. The eluate was
monitored by TLC and combined to 19 fractions (O.E1 – O.E19).
Fraction O.E3 (CH2Cl2/MeOH, 99.7: 0.3) was recrystallized in
CH2Cl2 to yield compound 1 (37.62 mg). Fraction O.E7 (CH2Cl2/
MeOH, 99.5: 0.5; 35.46 mg) was puriﬁed by Sephadex LH-20
column chromatography using MeOH as mobile phase, yielding
15.44 mg of compound 2. Fraction O.E11 (CH2Cl2/MeOH, 97: 3;
91.24 mg) was rechromatographed by Sephadex LH-20 column
chromatography using MeOH as mobile phase, yielding 8 fractions
(OE.11.1 – OE.11.8) and compound 3 in fraction O.E11.5 (31.25 mg).
Compound 4 (4.69 mg) was obtained by separation of fraction
OE.11.7 by Sephadex LH-20 column chromatography with MeOH
as mobile phase.
Since the minor compounds of the ethyl acetate extract were
also present in a higher amount in the n-butanol extract (veriﬁed
by HPLC-MS-experiments), the isolation work was carried out
using the n-butanol extract. The n-butanol extract was re-
dissolved in methanol. The MeOH-soluble part was fractioned by
Sephadex LH-20 column chromatography with MeOH as mobile
phase to yield 10 fractions (OB.1–OB.10). Fraction OB.4 (338.60 mg)
was puriﬁed by means of FCPC using a solvent mixture of chloro-
form, methanol, water (9.5:10:5, all v/v, lower phase:mobile phase) to
yield compound 5 (26.68 mg) and compound 8 (13.59 mg). Subfrac-
tion OB.4.2 (28.70 mg) was further separated with Sephadex LH-20
column chromatography using a mixture of methanol and water
(1þ1, v/v) as mobile phase to obtain compound 10 (5.34 mg) and
compound 7 (4.90 mg). The MeOH-insoluble part of the n-butanol
extract was separated by FCPC using the solvent system ethyl acetate,
ethylene glycol dimethyl ether and water (2:1:2, upper phase:mobile
phase), yielding 11 fractions (OBI.1–OBI.11). Fraction OBI.2 (16.63 mg)
and fraction OBI.5 (9.50 mg) were rechromatographed by Sephadex
LH-20 column chromatography using a mixture of methanol and
water (1:1, v/v) as mobile phase to afford compound 9 (8.91 mg) and
compound 6 (3.55 mg), respectively (Fig. 1).
3. Results and discussions
3.1. NF-κB inhibitory activities of dichloromethane and methanol
extracts of 17 Vietnamese medicinal plants
In a primary screen, 40 different extracts of 17 plants were
analyzed for their potential to inhibit TNF-α induced NF-κB
activation in HEK-293 cells at a concentration of 10 mg/mL. Results
are presented in Fig. 2. Strongest inhibition of NF-κB activation was
found for Chromolaena odorata (DCM extract of the leaves) and
Oroxylum indicum (DCM extract of the stem bark). In contrast to a
previous study (Nguyen and You, 2009) dichloromethane and
methanol extracts of Smilax glabra at a concentration of 10 mg/mL
did not show any effect, whereas the dichloromethane extract of
Chromolaena odorata (at 10 mg/mL) was found to abrogate activation
of NF-κB to a higher degree as the positive control (at 10 mM). In the
study of Nguyen and You (2009) methanol extracts of both species
exhibited some minor NF-κB inhibitory effects (o25% at 30 mg/mL).
The rather strong effect of the dichloromethane extract of Chromo-
laena odorata in comparison to that of the methanol extract might be
Table 1
Latin names, plant parts and traditional uses of selected plant species in the screening for NF-κB inhibitors.
Latin name Family Plant part Voucher
specimen
Traditional uses (National Institute of Medicinal Materials,
2004)
Abutilon indicum (L.) Sweet Malvaceae Aerial part DN101 Treatment of fever, rheumatism, dysuria, carbuncle
Achyranthes aspera L. Amaranthaceae Root, aerial
part
DN102 Treatment of rheumatism, contusion, osteodynia, dysuria
Barleria lupulina Lindl. Acanthaceae Aerial part DL101 Treatment of snake-bites, bleeding wounds, rheumatism
Coptosapelta tomentosa (Blume) Vahl.ex Heyne var.
dongnaiensis (Pit.) Phamh.
Rubiaceae Stem, root KH081 Treatment of bleeding wounds, contusion or used as a tonic
Dischidia rafﬂesiana Wall. Asclepiadaceae Pitcher-
shaped leaf
PQ101 Treatment of rheumatism, snake-bites, jaundice or used as
a tonic
Drynaria quercifolia (L.) J.Sm. Polipodiaceae Rhizome DN103 Treatment of rheumatism, osteodynia, dentagia
Chromolaena odorata (L.) syn.: Eupatorium odoratum L.
King et Robinson
Asteraceae Aerial part LA103 Treatment of diarrhea, rheumatism, burns, skin wounds
Ficus pumila L. Moraceae Stem, leaf BMT101 Treatment of rheumatism
Gleditsia fera (Lour.) Merr. Caesalpiniaceae Thorn Treatment of carbuncle, osteodynia
Ipomoea biloba Forsk. syn.: Ipomoea pes-carprae (L.)
Sweet
Convolvulaceae Aerial part PT101 Treatment of fever, rheumatism, edema, snake-bites
Justicia gendarussa L. syn.: Gendarussa vulgaris Nees Acanthaceae Aerial part DL102 Treatment of osteodynia, rheumatism, jaundice, hives
Leea rubra Blume Leeaceae Root BT101 Treatment of rheumatism
Momordica cochinchinensis (Lour.) Spreng. Cucurbitaceae Seed DL103 Treatment of carbuncle, contusion, swelling
Oroxylum indicum (L.) Vent Bignoniaceae Stem bark Oro-1, Oro-2,
Oro-3, Oro-4
Treatment of allergy, inﬂammation, jaundice
Parabarium micranthum (Wall.) Pierre ex Spire Apocynaceae Stem DN104 Treatment of rheumatism, osteodynia
Scoparia dulcis L. Scrophulariaceae Aerial part DN105 Treatment of diabetes, hypertension, sore throat, used as an
antidote
Smilax glabra Roxb. Smilacaceae Rhizome DN106 Treatment of syphilis, acute and chronic nephritis, metal
poisoning, rheumatism
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due to lipophilic constituents extractable by means of apolar solvents
but not or only to some extent by polar ones. This is consistent with a
recent investigation which identiﬁed six fatty acids as well as
scutellarein tetramethyl ether from Chromolaena odorata (Tran
et al., 2011) as inhibitors of NF-κB activation. Further differences in
the obtained ﬁndings might be a result of discrepancies in prepara-
tion of extracts, the setup of the in vitro assay, the selected sample
concentration, and varying contents of active substances in the plant
raw material, depending on harvest time and other inﬂuences.
NFκB inhibitory effects of the ethyl acetate extract of Oroxylum
indicum were already reported by Siriwatanametanon et al. (2010),
but the active principles were not determined. In the present
study the dichloromethane extract of Oroxylum indicum was
investigated and identiﬁed also as an inhibitor of NF-κB activation.
Thus, both dichloromethane and ethyl acetate extracts were
subjected to further phytochemical analysis.
3.2. Isolation of single constituents from the active fraction of
Oroxylum indicum
Fig. 3 shows HPLC-DAD chromatograms of dichloromethane
and ethyl acetate extracts of the stem bark of Oroxylum indicum.
Compounds 1–3 are the main constituents of both extracts, while
compounds 4–8 were not present in the dichloromethane extract.
Therefore, a large scale ethyl acetate extract was prepared. Since
compounds 5–8 were found in higher amounts in the n-butanol
extract, isolation of these compounds was conducted using the
n-butanol extract. After several puriﬁcation steps by means of
silica gel column chromatography, gel-ﬁltration chromatography
and counter-current chromatography, four ﬂavonoid aglyca (1–4)
could be isolated from the ethyl acetate extract and six ﬂavonoid
glycosides from the n-butanol extract (5–10). 1H and 13C NMR, as
well as the 2-D-NMR data of compounds 1–8 were compared to
literature data and found to be in good agreement with reported
values (Mat Ali et al., 1998; Chen et al., 2003; Wu et al., 2005;
Yadav et al., 2012). Based on NMR data and molecular weight
determined by HPLC-MS, compounds 9 and 10 were identiﬁed as
two methyl ester derivatives of compounds 5 and 8, respectively.
13C NMR data of compounds 9 and 10 are shown in Supplementary
information together with the 1H NMR-spectra of compounds 1–4.
Structures of isolated compounds (1–10) are shown in Fig. 1.
3.3. Analysis of the NF-κB inhibitory effect of isolated compounds
from Oroxylum indicum
Ten isolated compounds from the bark of Oroxylum indicum
were analyzed in an NF-κB assay at a concentration of 30 mM. No
decrease in cell viability within the used experimental setup could
be observed. Interestingly, only the four ﬂavonoid aglyca inhibi-
ted the NF-κB reporter gene transcription while the six ﬂavonoid
1. Oroxylin A R1 = H R2 = OCH3
R2 = OCH3
R2 = OCH3
R2 = OCH3
R3 = H
R3 = H
R3 = H
R3 = H
R3 = H
R3 = H
R3 = H
R3 = H
R3 = H
2. Chrysin R1 = H
R1 = H
R1 = H
R2 = H
R2 = H
3. Baicalein R2 = OH
R2 = OH
R2 = OH
4. Hispidulin R3 = OH
5. Oroxylin A-7-O-β-D-glucuronide R1 = glucuronic acid
6. Chrysin-7-O-β-D-glucuronide R1 = glucuronic acid
7. Baicalein-7-O-β-D-glucoside R1 = glucose R = OH
8. Baicalein-7-O-β-D-glucuronide (Baicalin) R1 = glucuronic acid
9. Oroxylin A-7-O-β-D-methyl glucuronide R1 = methyl glucuronide
10. Baicalein A-7-O-β-D-methyl glucuronide R1 = methyl glucuronide
Fig. 1. Structures of compounds (1–10) isolated from the stem bark of Oroxylum indicum.
Fig. 2. Effect of plant extracts (10 mg/mL) on NF-κB activation in HEK-293/NF-κB-luc cells; negative control: cells were treated with solvent vehicle (DMSO, 0.1%) and
stimulated with TNF-α (2 ng/mL); positive control: cells were treated with parthenolide (10 mM) and stimulated with TNF-α. AP¼aerial part; R¼roots; St¼stems; L¼ leaves;
R¼roots; Se¼seeds; Th¼thorns. The ﬁrst letters of genus and species name of each plant were used to abbreviate plant names; see Table 1 for full names. Data points
represent mean7S.E.M.; n¼3, *po0.05 (ANOVA/Tukey) compared with negative control.
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glycosides showed no signiﬁcant activity (Fig. 4). The anti-inﬂ-
ammatory activity of compound 8, baicalin, which is the glycoside
of baicalein has been previously studied in several in vivo tests.
Cytoprotective properties against injury to the liver caused by
ischemia/reperfusion (Kim et al., 2010) and neuroprotective effects
against ischemic reperfusion injury in rats (Xue et al., 2010) were
reported to be related to inhibition of NF-κB. However, in an
interleukin-1β (IL-1β) induced human retinal pigment epithelial cell
line (Nakamura et al., 2003), baicalin neither inhibited IL-1β-induced
IL-6 and IL-8 protein and mRNA production, nor did this ﬂavonoid
inhibit activation of NF-κB. Herein, we conducted the NF-κB assay
with baicalein and baicalin simultaneously to demonstrate clearly
the difference in activity between the ﬂavonoid aglycone and its
glycoside derivative in vitro. The result showed that baicalein was
active while its glycoside, baicalin, did not suppress NF-κB activity in
the HEK293/NF-κB-luc cell system. The same phenomenon was also
observed with the glycosides of chrysin and oroxylin A and their
corresponding aglyca. The increase in polarity and molecular weight
due to the sugar moiety which negatively inﬂuences the penetration
of cell membranes could be one explanation for the loss of activity of
the glycosides.
3.4. IC50 determination of the active ﬂavonoids
In order to establish a preliminary structure-activity relationship
and to assess the contribution of the four active ﬂavonoids (hispidu-
lin, baicalein, chrysin and oroxylin A) to the inhibitory effect on NF-κB
activation of the Oroxylum indicum extract, IC50 values were deter-
mined. Oroxylin A was the most active substance (IC50¼3.9 mM,
95% CI: 3.5–4.4 mM) while chrysin and hispidulin showed lower
activity (IC50¼7.2 mM, 95% CI: 6.0–8.8 mM, and 9.0 mM, 95% CI: 7.9–
10.2 mM, respectively) in our cell based test system. Interestingly,
baicalein revealed only a weak activity (IC50¼28.1 mM, 95% CI: 24.6–
32.0 mM) (Fig. 5). Baicalein, chrysin and oroxylin A are known for
their anti-inﬂammatory effects attributed at least partially through
the suppression of NF-κB activation (Chen et al., 2000; Kang et al.,
2003; Ma et al., 2005; Shin et al., 2009; Sala et al., 2011) but this is the
ﬁrst time hispidulin was found to inhibit NF-κB activation. The results
suggest that the presence of a hydroxyl group at the position 6 of the
A ring (baicalein) reduces the activity of the ﬂavone while a methoxyl
group or no substitution at position 6 of the A ring (oroxylin A,
hispidulin, chrysin) leads to a better inhibitory activity. Hispidulin
possesses a similar structure to oroxylin A except for one additional
hydroxyl group at position 40 of the B ring. This modiﬁcation results
in a decrease of the ability to suppress NF-κB activation. These results
supplement studies by Chen et al. (2004) who described the signi-
ﬁcance of hydroxyl groups at position 5 and 7 of the A ring and
at position 40 of the B ring for the effect of ﬂavonoids in inhibiting
ICAM-1, NF-κB and AP-1 activities on respiratory epithelial cells. Shin
et al. (2011) studied the relationship among chalcone, ﬂavanone,
ﬂavone and isoﬂavone derivatives and their inhibitory effect on TNF-
α-induced NF-κB activation in HCT116 human colon cancer cell and
emphasized the importance of hydroxyl substituents at C-5 position
of the A ring of ﬂavones.
3.5. Quantiﬁcation of the active ﬂavonoids (hispidulin, baicalein,
chrysin and oroxylin A) in extracts and plant materials
Since baicalein was thought to be responsible for the anti-
inﬂammatory activity of Oroxylum indicum, but showed only a
weak NF-κB activity in this study, quantiﬁcation of four ﬂavonoids
(hispidulin, baicalein, chrysin and oroxylin A) in the active extracts
and stem bark materials was performed to get an idea about the
contribution of each compound to the inhibitory effect on TNF-α-
induced NF-κB activation. Validation of the established HPLC-DAD
method is presented in Supplementary information. In the dichlor-
omethane extract, hispidulin could not be determined; the con-
tents of baicalein, chrysin and oroxylin A were 13.43%, 1.72%, 8.56%
(w/w), respectively. These compounds were more abundant in the
ethyl acetate extract: hispidulin (2.00%), baicalein (15.96%), chrysin
(3.40%) and oroxylin A (13.85%, w/w). In both extracts the content
of baicalein was higher than that of oroxylin A; however, the IC50
value of baicalein (IC50¼28.1 mM) is almost 7 times higher than
that of oroxylin A (IC50¼3.9 mM). Therefore, it can be assumed that
the NF-κB inhibitory activity of the dichloromethane and the ethyl
acetate extracts is more driven by oroxylin A, although synergistic
effects can never be ruled out. We also analyzed the content of the
active ﬂavonoids in four different Oroxylum indicum stem bark
samples. The results (see Table 2) showed a strong variation in the
different samples. In general, baicalein (0.13–0.45%) was the
dominant ﬂavonoid aglycone in the stem bark, followed by
oroxylin A (0.09–0.14%).
Oroxylum indicum is used in many Asian countries; however,
different parts of the plant are often used. The seeds of Oroxylum
indicum are described in the Chinese Pharmacopeia (The State
Pharmacopoeia Commission of P.R. China, 2010) while the stem
bark is present in the Vietnamese Pharmacopoeia (The State
Pharmacopoeia Commission of Vietnamese Pharmacopoeia, 2009).
Fig. 3. HPL chromatograms of (A) dichloromethane extract and (B) ethyl acetate
extract monitored at wavelength of 275 nm; for HPLC conditions see Section 2.
Compound assignment: 1—Oroxylin A; 2—Chrysin; 3—Baicalein; 4—Hispidulin; for
other compounds see Fig. 1.
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In the Ayurvedic system of medicine, the root bark is the ofﬁcially
used part of Oroxylum indicum (Radhika et al., 2011). Due to the
popularity of this herbal medicine, several analytical procedures have
been reported for the detection of ﬂavonoids in different plant parts.
Interestingly, hispidulin was not detected in the seeds (Krüger and
Ganzera, 2012), while all four compounds (hispidulin, baicalein,
chrysin and oroxylin A) were detected simultaneously in the root
bark (Yadav et al., 2012). Among the quantiﬁed ﬂavonoids, baicalein
was the dominant ﬂavonoid aglycone in all plant parts of Oroxylum
indicum, 0.09–0.18% in the seeds (Krüger and Ganzera, 2012), 0.13–
0.45% in the stem bark (Table 2), and 0.67% in the roots (Yadav et al.,
2012).
4. Conclusion
Ethnopharmacological knowledge is a promising source for the
selection of potential bioactive plant material. Among 17 Vietnamese
plants used for the treatment of a variety of diseases associated with
inﬂammation, the dichloromethane extracts of Chromolaena odorata
and Oroxylum indicum proved to be promising inhibitors of the NF-κB
pathway. A previous study identiﬁed fatty acids of Chromolaena
odorata as inhibitors of NF-κB activation (Tran et al., 2011) but since
the main constituents of this plant (Dat et al., 2009) are ﬂavonoids, it
might be necessary to consider a contribution of these compounds to
the NF-κB inhibitory effect of this plant. Phytochemical studies of
Oroxylum indicum bark led to the identiﬁcation of four bioactive
ﬂavonoids (hispidulin, baicalein, chrysin, and oroxylin A). Baicalein
and its glycoside, baicalin, are well known for their anti-inﬂammatory
activity related to the inhibition of NF-κB activation. However, in this
study, simultaneous testing with other constituents of Oroxylum
indicum, baicalein showed a weak activity while baicalin was inactive,
whereas other ﬂavonoids e.g. oroxylin A seem to be more important in
respect to the NF-κB inhibitory effect of Oroxylum indicum extracts.
Altogether, the performed study supports the traditional use of some
of the investigated species against inﬂammation by the found in vitro
activity and identiﬁed the stem bark of Oroxylum indicum as a valuable
source of ﬂavonoids with an anti-inﬂammatory activity.
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